![Jordan Zwick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 704 129 $ in data 30/06/2026
Mr. Jordan Zwick is a Venture Partner at ARCH Venture Partners LLC, an Independent Director at Palisade Bio, Inc. and an Independent Director at Theratechnologies, Inc. He is on the Board of Directors at Palisade Bio, Inc. and Theratechnologies, Inc.
Mr. Zwick was previously employed as a SVP-Corporate Business Development by Amarin Corp.
Plc, a Head-Strategy by Salix Pharmaceuticals Ltd., a Trading Associate by Raymond James & Associates, Inc., and a Chief Strategy Officer by InflaRx NV.
He received his undergraduate degree from Florida Atlantic University, a graduate degree from Florida Atlantic University and an MBA from the University of San Francisco.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 10/06/2026 | 336.904 ( 0,2% ) | 704 129 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| THERATECHNOLOGIES INC. | Direttore/Membro del Consiglio | 21/03/2024 |
| PALISADE BIO, INC. | Direttore/Membro del Consiglio | 10/06/2026 |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Investitore di Private Equity | 01/07/2026 |
| Società | Posizione | Fine |
|---|---|---|
| AMARIN CORPORATION PLC | Corporate Officer/Principal | 01/01/2023 |
| INFLARX N.V. | Corporate Officer/Principal | 29/06/2022 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 01/01/2020 |
Raymond James & Associates, Inc.
 Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 9 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
Raymond James & Associates, Inc.
Raymond James & Associates, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Theratechnologies, Inc.
 Theratechnologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Florida Atlantic University
 Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
